ROX NHS ester, 6-isomer
| Cat. # | Quantity | Price | Lead time | Buy this product |
|---|---|---|---|---|
| 12220 | 1 mg | $110 | in stock | |
| 22220 | 5 mg | $210 | in stock | |
| 42220 | 25 mg |
$410
|
in stock | |
| 52220 | 50 mg |
$695
|
in stock | |
| 62220 | 100 mg |
$1190
|
in stock |
ROX (Rhodamine X, R101) is a highly fluorescent, and photostable rhodamine dye for various applications. ROX labeled oligonucleotide probes are often used in qPCR, and qPCR instruments have ROX channel.
This is reactive dye for the labeling of amino-groups in peptides, proteins, and amino-oligonucleotides. Pure single isomer.
Absorption and emission spectra of ROX dye
Customers also purchased with this product
BDP® TR-X-NHS ester
BDP TR-X-NHS ester is a derivative of BDP TR containing a long linker based on aminohexanoic acid (C6). The dye has absorption and emission close to ROX. The NHS ester function can be used to conjugate proteins and peptides.sulfo-Cyanine7 azide
Water-soluble NIR fluorescent dye azide for click chemistry.BDP® R6G NHS ester
BDP R6G is a borondipyrromethene dye which has absorption and emission spectra similar to R6G.
Add this product to your cart andget free express delivery
General properties
| Appearance: | dark crimson powder |
| Mass spec M+ increment: | 516.2 |
| Molecular weight: | 631.67 |
| CAS number: | 117491-83-5; 1890922-83-4; 216699-36-4 |
| Molecular formula: | C37H33N3O7 |
| Solubility: | good in polar organic solvents (DMF, DMSO), low in water |
| Quality control: | NMR 1H, HPLC-MS (80+%, balance mostly free carboxylic acid) |
| Storage conditions: | Storage: 12 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. Desiccate. |
| MSDS: | Download |
| Product specifications |
Spectral properties
| Excitation/absorption maximum, nm: | 570 |
| ε, L⋅mol−1⋅cm−1: | 88000 |
| Emission maximum, nm: | 591 |
| Fluorescence quantum yield: | 1.0 |
| CF260: | 0.62 |
| CF280: | 0.49 |
Product citations
- Konopka, C.J.; Wozniak, M.; Hedhli, J.; Ploska, A.; Schwartz-Duval, A.; Siekierzycka, A.; Pan, D.; Munirathinam, G.; Dobrucki, I.T.; Kalinowski, L.; Dobrucki, L.W. Multimodal imaging of the receptor for advanced glycation end-products with molecularly targeted nanoparticles. Theranostics, 2018, 8(18), 5012–5024. doi: 10.7150/thno.24791
The count of items is incorrect.
Your cart is empty
$ 
